Modeling of Xerostomia After Radiotherapy for Head and Neck Cancer: A Registry Study

by Eva Onjukka, Eva Onjukka, Claes Mercke, Claes Mercke, Einar Björgvinsson, Anna Embring, Anna Embring, Anders Berglund, Gabriella Alexandersson von Döbeln, Signe Friesland, Signe Friesland, Giovanna Gagliardi, Clara Lenneby Helleday, Helena Sjödin, Ingmar Lax
Published 2020-08-01

Overlapping volumes in re-irradiation for head and neck cancer – an important factor for patient selection

by Anna Embring, Eva Onjukka, Claes Mercke, Ingmar Lax, Anders Berglund, Sara Bornedal, Berit Wennberg, Signe Friesland
Published 2020-06-01

Re-Irradiation for Head and Neck Cancer: Cumulative Dose to Organs at Risk and Late Side Effects

by Anna Embring, Eva Onjukka, Claes Mercke, Ingmar Lax, Anders Berglund, Sara Bornedal, Berit Wennberg, Emmy Dalqvist, Signe Friesland
Published 2021-06-01

Initial experience with introducing national guidelines for CT- and MRI-based delineation of organs at risk in radiotherapy

by Caroline Olsson, Tufve Nyholm, Elinore Wieslander, Eva Onjukka, Adalsteinn Gunnlaugsson, Johan Reizenstein, Stefan Johnsson, Ingrid Kristensen, Johan Skönevik, Magnus Karlsson, Ulf Isacsson, Anna Flejmer, Edvard Abel, Fredrik Nordström, Leif Nyström, Kjell Bergfeldt, Björn Zackrisson, Alexander Valdman
Published 2019-07-01

External Validation of a Predictive Model of Urethral Strictures for Prostate Patients Treated With HDR Brachytherapy Boost

by Vanessa Panettieri, Vanessa Panettieri, Tiziana Rancati, Eva Onjukka, Martin A. Ebert, Martin A. Ebert, Martin A. Ebert, David J. Joseph, David J. Joseph, David J. Joseph, James W. Denham, Allison Steigler, Jeremy L. Millar, Jeremy L. Millar
Published 2020-06-01